MRK - Pyxis Oncology rises on FDA fast track tag for lead asset
2025-02-26 07:55:47 ET
Shares of Pyxis Oncology ( NASDAQ: PYXS ) traded higher in the premarket on Wednesday after the U.S. FDA issued its Fast Track Designation for the company’s lead candidate, PYX-201, targeted at head and neck cancer....
Pyxis Oncology rises on FDA fast track tag for lead asset